Aarti Pharmalabs Limited Financial Flexibility Index

Latest as of September 2023: 0.06x

Aarti Pharmalabs Limited financial flexibility index. Aarti Pharmalabs Limited (AARTIPHARM) has a Financial Flexibility Index of 0.06x as of September 2023. Free cash flow of Rs362.80 Million (operating CF Rs362.80 Million minus capex Rs0.00) represents 0% of total liabilities (Rs6.56 Billion). See Aarti Pharmalabs Limited (AARTIPHARM) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.

Financial Flexibility Index

0.06x
Free Cash Flow / Total Liabilities

Free Cash Flow

Rs362.80 Million
Operating CF − Capex

Total Liabilities

Rs6.56 Billion
INR

Capital Expenditures

Rs0.00
INR

Financial Flexibility Index of Aarti Pharmalabs Limited (2020–2025)

Financial flexibility index of Aarti Pharmalabs Limited from 2020 to 2025. Historical Financial Flexibility Index trend for Aarti Pharmalabs Limited across 6 annual periods. Check Aarti Pharmalabs Limited (AARTIPHARM) cash earnings ratio to evaluate the quality of earnings relative to operating cash generation.

Aarti Pharmalabs Limited Financial Flexibility Index by Year (2020–2025)

Aarti Pharmalabs Limited financial flexibility index by year from 2020 to 2025. Year-by-year free cash flow to debt coverage for Aarti Pharmalabs Limited. For the full cash flow conversion analysis, see Aarti Pharmalabs Limited cash flow conversion.

Year Flexibility Index Free Cash Flow (INR) Operating CF Total Liabilities YoY Change
2025 0.80x Rs7.34 Billion Rs3.32 Billion Rs9.16 Billion ▲ +59.1%
2024 0.50x Rs4.15 Billion Rs2.16 Billion Rs8.25 Billion ▼ -9.9%
2023 0.56x Rs3.83 Billion Rs2.63 Billion Rs6.86 Billion ▲ +274.3%
2022 0.15x Rs974.48 Million Rs-437.04 Million Rs6.53 Billion —
2021 0.00x Rs0.00 Rs0.00 Rs232.71K ▲ +100.0%
2020 -1.00x Rs-186.75K Rs-186.75K Rs186.75K —
Financial Flexibility Index = (Operating CF − Capex) / Total Liabilities = Free Cash Flow / Total Liabilities